The legacy of Viagra and its parent , copyright, presents a complex picture for prospective investors. While the iconic drug initially generated enormous profits , its exclusivity has ended, leading to rival alternatives flooding the market . This decline in pricing presents a real hurdle for copyright and any fund considering a significant stak⦠Read More